研究者会议能否提高临床试验招募率?九项多中心试验的回顾性前后对照研究
该研究回顾性分析诺丁汉临床试验单元九项多中心试验在研究者会议前后各8周的招募数据,共82个站点。
要点
- 研究者会议后8周内招募率无统计学显著增加。
- 参会站点与未参会站点的招募变化均无显著差异。
- 若仅以提升招募为目的,应考虑其他有证据支持的策略。
核心结论
- 无统计学证据表明研究者会议在会后8周内提高临床试验招募率。
- 若举办会议仅寄望于提升招募,试验者可考虑其他已知有效的招募策略。
- 研究者会议仍可作为与站点沟通的策略,因其举办有多种原因。
研究设计与样本
- 回顾性前后对照研究,分析诺丁汉临床试验单元九项多中心试验2014至2018年招募数据。
- 会议前8周内共82个站点开放招募,其中60个参会,22个未参会。
- 利用试验主文件中的参会数据和随机化数据集中的招募数据比较会议前后8周招募率。
主要发现
- 82个站点会议前8周招募284例,会议后8周招募300例。
临床怎么用
- 不应仅以提升招募率为目的举办研究者会议。
- 若需提高招募,应优先考虑其他有证据支持的策略。
- 研究者会议可作为站点培训、更新和最佳实践交流的沟通策略。
局限性
- 回顾性设计,仅纳入诺丁汉临床试验单元的九项试验,样本量有限。
- 仅观察会议后8周内的招募变化,未评估更长期影响。
- 未参会站点仅22个,组间比较效力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor recruitment in clinical trials is well-documented. In large, multi-centre trials, communication between the coordinating centre and trial sites is essential. A commonly used communication tool is the hosting of an investigator/collaborator meeting, which offers an opportunity for sites to re-train and receive trial updates, learn from each other, share best practice and troubleshoot issues. Anecdotally, there is a perception that recruitment rates may increase after holding such a meeting. The aim of this before-and-after study was to examine any changes in recruitment after an investigator meeting. METHODS: We conducted a retrospective study of nine trials at the Nottingham Clinical Trials Unit (NCTU) that were open to recruitment between 2014 and 2018. In the 8 weeks prior to the date of the investigator meeting, 82 sites (across nine trials) were open to recruitment; 60 of which attended the meeting, 22 who did not. Using meeting attendance data available in Trial Master Files (TMF) and recruitment data from randomisation datasets, we examined recruitment rates in the 8 weeks prior to and following the date of the investigator meeting. RESULTS: For the 82 sites included, 284 participants were recruited in the 8 weeks prior to the meeting, with a further 300 participants recruited in the 8 weeks post meeting. This gives a mean change in weekly recruitment of 0.073 (- 0.129, 0.275) per site, demonstrating no statistically significant increase in recruitment after the investigator meeting. For the 60 attending sites, recruitment increased from 254 participants prior to the meeting to 271 post meeting, giving a 0.100 (- 0.160, 0.360) mean change in weekly recruitment per site, providing no evidence that recruitment rates increase following an investigator meeting. CONCLUSION: There is no statistical evidence to conclude that holding an investigator meeting increases recruitment in the 8 weeks following the meeting. Thus, if the meeting has been held in the belief that it will have a positive impact upon recruitment, trialists may wish to consider other evidence-based strategies known to increase recruitment rates. However, since there are a variety of reasons why an investigator meeting may be held, trialists should continue to consider this as a communication strategy with sites.
引用
- Mitchell EJ, Godolphin PJ, Meakin G, et al. Do investigator meetings improve recruitment rates in clinical trials? A retrospective before-and-after study of data from nine multi-centre clinical trials. Trials. 2020. PMID: 32522228. doi:10.1186/s13063-020-04465-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。